Getting to the Heart of the Matter: Medscape Education at AHA 2024!
November 12, 2024 | AHA24, CME, Cardiovascular, Symposia, cardiology, cardiomyopathy, hypertension
Come join Medscape Education at the American Heart Association (AHA) 2024 Scientific Sessions in Chicago, IL, from November 16-18 — a dynamic event packed with cutting-edge cardiology education that you won’t want to miss! 🚀 This year, we are hosting 6 highly interactive symposia, each designed to elevate the learner’s expertise and knowledge, while diving deep into the latest advancements in Cardiology!
Key Symposia at AHA 2024
Our carefully curated symposia cover a broad range of critical cardiology topics, ensuring that attendees are well-equipped to tackle emerging challenges in cardiovascular health. Here’s a preview of what you can expect:
Saturday, November 16
1. Proactive Cardiovascular Protection Along the Cardiac Continuum: Understanding Risk to Optimize Prevention: Explore cutting-edge strategies in proactive cardiovascular protection. By understanding the full spectrum of cardiovascular risk, we can improve prevention efforts and outcomes.
2. Navigating New Paradigms in Thrombosis Management: Gameshow Evaluation of Evolving Anticoagulation Approaches: This interactive “gameshow” format, is designed to engage learners in the latest advancements in anticoagulation therapies and their role in thrombosis management.
Sunday, November 17
3. From Challenge to Control: Innovative Therapies in Hypertension Management: Discover the recent innovations in the treatment of hypertension, including novel therapies and management strategies aimed at overcoming the challenges faced by clinicians.
4. Transforming Perspectives on Transthyretin Amyloid Cardiomyopathy: Insights Into Evolving Advances: Learn about recent advances in diagnostics and treatment options for Transthyretin amyloid cardiomyopathy.
5. Heart Failure with Preserved or Mildly Reduced Ejection Fraction: Impacting Health Outcomes with Nonsteroidal MRAs: Explore how the use of nonsteroidal mineralocorticoid receptor antagonists (MRAs) can improve outcomes in patients with heart failure, particularly those with preserved or mildly reduced ejection fraction.
6. Hypertrophic Cardiomyopathy Masterclass: Rapid Fire Case Consults: In this hands-on masterclass, we will work through real-life hypertrophic cardiomyopathy (HCM) cases, providing expert insights and interactive discussions on the latest diagnostic and therapeutic approaches.
These sessions are more than just symposia— they offer an opportunity to engage with leading cardiology experts, participate in thought-provoking discussions, and gain insights that can immediately enhance clinical practice. Don’t miss this chance to take your cardiology practice to the next level. Register today and secure your spot for these educational opportunities!
Additionally, be sure to join us for a highly anticipated oral presentation on “Echocardiography in Hypertrophic Cardiomyopathy: Virtual CME Advances Physician Knowledge and Confidence,” November 18th from 9:40 am – 9:45 am, during the Imaging and Technologies in Heart Failure digital poster session.
For more information on Cardiology Education, contact David Anderson.
We look forward to seeing you at AHA 2024 in Chicago, IL!
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Contagious Conversations: Exploring Infectious Disease in the Digital Age
As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...
Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...
Impacting Lives with Rare Disease Education
Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...
Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D
An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...
A Rare Disease Update from Medscape Education
A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency
New Outcomes Are a Breath of Fresh Air at ERS
ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...
Medscape Education Launches 20th Older Driver Safety Educational Program
Education Supported by the National Highway Traffic Safety Administration
Protecting the Heart Through Education at ESC 2023
Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...
Medscape’s Rare Disease Learning Center Has Reached 1 Million Learners
The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...
Continuing Medical Education Outcomes are Much More Than Statistical Significance
At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...